Ascentage Grosses $126.4m In First Biopharma IPO In The US For 2025

 
• By Joseph Haas
  
IPO
Ascentage lands the first biopharma IPO of 2025 • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Financing

More from Focus On Asia